[EN] AMINOTRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES<br/>[FR] AMINOTRIAZOLES POUR TRAITER DES MALADIES DÉMYÉLINISANTES
申请人:VERTEX PHARMA
公开号:WO2018106646A1
公开(公告)日:2018-06-14
The invention relates to triazole compounds of formula (I') or pharmaceutically acceptable salts thereof, useful as modulators of demyelinating diseases: wherein A is selected from the group consisting of (i), (ii), (iii), (iv), (v), and (vi) The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention, methods of using the compositions and kits thereof in the treatment of various demyelinating and neurodegenerative diseases, including multiple sclerosis.
该发明涉及式(I')的三唑化合物或其药学上可接受的盐,用作脱髓鞘疾病的调节剂:其中A选自(i)、(ii)、(iii)、(iv)、(v)和(vi)所述的组。该发明还提供包括该发明化合物的药学上可接受的组合物,以及在治疗各种脱髓鞘和神经退行性疾病,包括多发性硬化症中使用这些组合物和配套工具的方法。